Wedbush Raises Vera Therapeutics' Price Target to $34 From $21 After Model Update, Maintains Neutral Rating
Wedbush Raises Vera Therapeutics' Price Target to $34 From $21 After Model Update, Maintains Neutral Rating
模型更新后，Wedbush将Vera Therapeutics的目标股价从21美元上调至34美元，维持中性评级
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册